Certain information contained within this Announcement is
deemed by the Company to constitute inside information as
stipulated under the UK Market Abuse Regulation ("MAR") as applied
in the United Kingdom. Upon publication of this Announcement, this
information is now considered to be in the public
domain.
MyHealthChecked
PLC
("MyHealthChecked" or
the "Company")
Exercise of
Options
MyHealthChecked PLC (AIM: MHC), the
consumer home-testing healthcare company, announces
that the Company has received a request to exercise options
over 30,000 ordinary shares of 1.5p each in the Company. The
request has been satisfied by the allotment on 20 December 2024 of
new ordinary shares issued under the Company's allotment
authorities.
The New Ordinary Shares rank
pari passu in all respects
with the Company's existing Ordinary Shares. An application will be
made to the London Stock Exchange for the 30,000 New Ordinary
Shares (the "New Ordinary Shares") to be admitted to trading on AIM
("Admission"). Admission is expected to occur at 8.00am on or
around 31 December 2024.
The options, the subject of the
request, had an exercise price of 9.5 pence per share.
Admission of shares and total voting rights
Following Admission, the total
issued share capital of the Company will consist of 52,035,932
ordinary shares. As each ordinary share carries the right to
one vote, the total number of voting rights in the Company will be
52,035,932. This number may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For
further information contact:
MyHealthChecked plc
|
www.myhealthchecked.com
|
Penny McCormick, Chief Executive
Officer
|
via
Walbrook PR
|
|
|
SPARK Advisory Partners Limited (NOMAD)
|
Tel: +44
(0)20 3368 3550
|
Neil Baldwin / Jade Bayat
|
|
|
|
Dowgate Capital Limited (Broker)
|
Tel: +44
(0)20 3903 7715
|
David Poutney / Nicholas
Chambers
|
|
|
|
Walbrook PR Ltd (Media & IR)
|
Tel: +44
(0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
|
Paul McManus / Alice
Woodings
|
Mob: +44 (0)7980 541 893 / +44(0)7407 804
654
|
|
|
|
|
|
|
| |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in
Cardiff, is an AIM-quoted pioneering UK healthcare company focused
on a range of at-home healthcare and wellness tests.
MyHealthChecked is
the umbrella brand of a range of at-home rapid tests, as well as
DNA, RNA and blood sample collection kits which have been created
to support customers on their journeys to wellness. The tests are
lateral-flow self-tests, whilst the sample collection kits enable
the collection of blood, urine, nasal or mouth swab samples that
are analysed in partner laboratories for a range of biomarkers. The
tests have been made available online and for over-the-counter
purchase.
The MyHealthChecked portfolio has
been identified as part of a change in mindset as customers become
more familiar with the concept of accessible healthcare in the
growing at home testing kit market with a focus on accessibility at
the right price, led by UK-based experts.